Yield Theory
Sign inSubscribe

Stock research

DexCom, Inc. DXCM

DexCom makes continuous glucose monitoring systems that help people with diabetes track blood sugar.
Ticker
DXCM
Exchange
NASDAQ
Sector
Health
Founded
—

What moves DXCM

DexCom, Inc. sits in Health Care. Pharmaceuticals, biotech, medical devices, and managed care — defensive demand paired with binary drug and regulatory catalysts. The forces that matter most for the sector — and therefore for DXCM — are:

  • ◆Drug approvals and clinical-trial readouts
  • ◆Medicare and drug-pricing policy
  • ◆Demographics and an aging population
  • ◆GLP-1 and obesity-drug demand

Congressional trading in DXCM

From time to time, DexCom, Inc. shows up in the stock transactions members of Congress disclose under the STOCK Act. On its own that's just data — Yield Theory's job is to tell you whether it means anything.

We track these disclosures and read them as one input into the bigger picture: who is positioning, why, and what it implies for capital flows. See the congressional trades tracker for the lawmakers whose filings we watch most closely.

Lawmakers active in Health Care

Dan CrenshawRepresentative · R-TXRo KhannaRepresentative · D-CAMichael McCaulRepresentative · R-TXRick ScottSenator · R-FL

How Yield Theory covers DXCM

DXCM intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.

US markets

More Health Care stocks

Eli Lilly and Company (LLY)Johnson & Johnson (JNJ)UnitedHealth Group Incorporated (UNH)Merck & Co., Inc. (MRK)AbbVie Inc. (ABBV)Pfizer Inc. (PFE)

Keep learning

All stock researchBrowse every ticker we coverCongressional tradesWho's buying and sellingInvesting glossaryUnderstand the terms

DXCM — frequently asked questions

What sector is DXCM in?

DexCom, Inc. is classified in the Health Care sector and trades on the NASDAQ.

Do members of Congress trade DXCM?

Congressional trading in DXCM appears in public STOCK Act disclosures from time to time. Yield Theory folds notable political flows into its broader analysis.

Is DXCM a good investment?

We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.

This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.

Want the full thesis on DXCM?

Yield Theory members get macro-driven research and stock recommendations every month — with the catalysts and risks spelled out. Founding price $24.99/mo.

Get instant access →

$24.99/mo · cancel anytime · researched by humans